Munder Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Munder Capital Management’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$506K	Sell	338 -254	-43%	-$368K	﹤0.01%	504
2014 Q2	$811K	Sell	592 -21	-3%	-$24.4K	0.01%	458
2014 Q1	$851K	Hold	613	–	–	0.01%	452
2013 Q4	$610K	Hold	613	–	–	﹤0.01%	491
2013 Q3	$639K	Buy	613 +295	+93%	+$315K	0.01%	477
2013 Q2	$346K	Buy	+318	New	+$354K	﹤0.01%	525

Other funds holding VIRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCP

Lamond Capital Partners San Francisco, California $14.3M AUM 30.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Munder Capital Management's VIRX Position: Q3 2014 in Review

Munder Capital Management reduced its Viracta Therapeutics, Inc. Common Stock (VIRX) stake by 43% in Q3 2014, selling an estimated $368K and leaving 338 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Munder Capital Management first reported a position in VIRX in Q2 2013 and has held it in 6 quarters since. The position peaked at $851K in Q1 2014. 104 funds tracked by Wall St. Rank hold VIRX as of Q3 2014.

Munder Capital Management held 338 shares of Viracta Therapeutics, Inc. Common Stock worth $506K as of Q3 2014.
Munder Capital Management sold 254 Viracta Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $368K.
Viracta Therapeutics, Inc. Common Stock made up ﹤0.01% of Munder Capital Management's portfolio in Q3 2014, its #504 holding.
Munder Capital Management first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
Munder Capital Management's Viracta Therapeutics, Inc. Common Stock position peaked at $851K in Q1 2014.
104 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.